Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients

Free Radical Biology and Medicine

Volumn 31, Issue 2, 2001, Pages 233-241

  Clermont, Gaëlle ^a   Lecour, Sandrine ^a   Cabanne, Jean François ^b   Motte, Gérard ^c   Guilland, Jean Claude ^a   Chevet, Dominique ^a   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Moret Hospital   (France)

^c HÔPITAL SAINT JACQUES   (France)

Author keywords

Ascorbyl free radical; Atherosclerosis; Elastase activity; Free radicals; Hemodialysis; Nitric oxide; Oxidative stress; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ELASTASE; FREE RADICAL; PADGEM PROTEIN; SCAVENGER;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE ACTIVATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

AGED; ANTIOXIDANTS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; FEMALE; FREE RADICALS; HUMANS; KIDNEY, ARTIFICIAL; MALE; MIDDLE AGED; OXIDATIVE STRESS; PANCREATIC ELASTASE; PROSPECTIVE STUDIES; RENAL DIALYSIS; VITAMIN E;

EID: 0035879701     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00577-9     Document Type: Article

References (62)

1. Cardiovascular diseases in chronic renal failure
2. Oxidative stress in uremia: Impact on cardiac disease in dialysis patients
3. Morbidity and mortality on maintenance haemodialysis
4. Antioxidants and atherosclerotic heart disease
5. Development of oxidative stress in chronic kidney insufficiency following the progression of disease
6. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy
7. Pathophysiology of the oxidative stress and its implication in uremia and dialysis
8. Oxidative stress in haemodialysis
9. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: A possible explanation for the increased cardiovascular risk in these patients
10. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension
11. Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in hemodialysis
12. Nitric oxide release in the peripheral blood during hemodialysis
13. Nitric oxide, superoxide, and peroxynitrite: The good, the bad and the ugly
14. Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer
15. Imbalance of oxidants and antioxidants in haemodialysis patients
16. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and high flux biocompatible membrane
17. Neutrophil oxygen radical production by dialysis membranes
18. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrilonitrile membranes
19. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients
20. Platelet-leukocyte activation during hemodialysis detected with a monoclonal antibody to leukocyte integrin CD11b
21. Oxygen free radicals and platelet activation
22. Development of vitamin E-modified membrane
23. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: A preliminary characterization
24. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter
25. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients
26. I. Nkf-K/Doqi clinical practice guidelines for hemodialysis adequacy: Update 2000
27. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion
28. Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats
29. Protein measurement with the Folin phenol reagent
30. Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC fluorescence
31. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratio
32. A simple and sensitive chromogen assay for the measurement of elastase-type enzyme activity in human plasma
33. 15N in biological fluids
34. A chemiluminescence assay for the detection of reactive oxygen species produced by human neutrophils: In vitro comparison of vitamin E-modified multilayer hemodialysis filter with a polysulfone dialyzer
35. Does vitamin E bound on dialysis membrane improve the LDL susceptibility to oxidation? Lessons from an in vitro model
36. Reduction of neutrophil activation by vitamin E modified dialyzer membranes
37. Effect of vitamin E-bounded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients
38. Blood oxidative stress and lipoprotein oxidizability in hemodialyzed patients: Effect of the use of a vitamin E-coated dialysis membrane
39. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction
40. Are biocompatible membranes superior for hemodialysis therapy?
41. Ascorbate free radical as a marker of oxidative stress
42. Ascorbyl free radical as a reliable indicator of free-radical-mediated myocardial ischemic and post-ischemic injury. A real-time continuous ESR study
43. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62)
44. Neutrophil reactive oxygen species production during hemodialysis: Role of activated platelet adhesion to neutrophils through P-selectin
45. Specific cellular responses to alpha-tocopherol
46. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity
47. Vitamin E and vascular homeostasis: Implications for atherosclerosis
48. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
49. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers
50. Soluble P-selectin is released from activated platelets in vivo during hemodialysis
51. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
52. Vitamin E and heart disease: Basic science to clinical intervention trials
53. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association
54. Biological effects of oxidant stress in haemodialysis: The possible roles of vitamin E
55. Vitamin E as an antioxidant agent
56. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation
57. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages
58. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E)
59. Interaction of vitamin C and vitamin E during free radical stress in plasma: An ESR study
60. Ascorbate metabolism and its regulation in animals
61. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density protein
62. Role of nitric oxide in hemodialysis hypotension